Goldfarb SB, Sammons SL, Meisel JL, Pluard TJ, et al. Effects of Lasofoxifene Versus Fulvestrant on Vaginal and Vulvar Symptoms in Patients With ESR1-Mutated, ER+/HER2-, Metastatic Breast Cancer From the ELAINE 1 Study. Clin Breast Cancer 2024 Dec 13:S1526-8209(24)00339.
PMID: 39828494